Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants.

Wang, Xuejun; Yang, Yang; Song, Zhifei; Wang, Yiming; Yang, Peng; Li, Xinyu; Wang, Fei; Wang, Mingming; Shao, Liting; Wang, Shengqi

Wang, Xuejun; Yang, Yang; Song, Zhifei; Wang, Yiming; Yang, Peng; Li, Xinyu; Wang, Fei; Wang, Mingming; Shao, Liting; Wang, Shengqi.

Wang X; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yang Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Song Z; Youcare Pharmaceutical Group Co., Ltd., Beijing, China.
Wang Y; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Yang P; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Li X; College of Life Sciences, Henan Normal University, Xinxiang, China.
Wang F; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Wang M; Youcare Pharmaceutical Group Co., Ltd., Beijing, China.
Shao L; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Wang S; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, China.

J Med Virol ; 95(2): e28565, 2023 02.

Article in English | MEDLINE | ID: covidwho-2236842

Subject(s)

Antibodies, Neutralizing; SARS-CoV-2; Humans; SARS-CoV-2/drug effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antibodies, Neutralizing / SARS-CoV-2 Topics: Variants Limits: Humans Language: English Journal: J Med Virol Year: 2023 Document Type: Article Affiliation country: Jmv.28565

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google